Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Muhonen

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|November 1, 1996
Alport's syndrome in 78 patients: epidemiological and clinical studyH Pajari, H Kääriäinen, T Muhonen, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|July 14, 2012
Micrometre-scale refrigeratorsJuha T Muhonen, Matthias Meschke, Jukka P Pekola
Pediatric Nephrology (Berlin, Germany)|August 19, 1999
The burden of genetic disease and attitudes towards gene testing in Alport syndromeH Pajari, O Koskimies, T Muhonen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingI T Jantunen, V V Kataja, T T Muhonen
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, J P Turunen, T Muhonen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Decreasing CD4/CD8 ratio during prolonged four-drug chemotherapy plus interferon treatment for metastatic melanomaT Muhonen, M Hahka-Kemppinen, S Pakkala, et al.
Melanoma Research|June 1, 1996
Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?M Hahka-Kemppinen, T Muhonen, L Kangas, et al.
Melanoma Research|August 1, 1997
DNA flow cytometry and the outcome of chemoimmunotherapy in metastatic melanomaM Hahka-Kemppinen, T Muhonen, S Nordling, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1996
Radiation therapy of intracranial malignant melanomaO P Isokangas, T Muhonen, M Kajanti, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagusM Kajanti, R Kaleta, L Kankaanranta, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Acta Paediatrica (Oslo, Norway : 1992)|November 1, 1996
Alport's syndrome in 78 patients: epidemiological and clinical studyH Pajari, H Kääriäinen, T Muhonen, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|July 14, 2012
Micrometre-scale refrigeratorsJuha T Muhonen, Matthias Meschke, Jukka P Pekola
Pediatric Nephrology (Berlin, Germany)|August 19, 1999
The burden of genetic disease and attitudes towards gene testing in Alport syndromeH Pajari, O Koskimies, T Muhonen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingI T Jantunen, V V Kataja, T T Muhonen
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, J P Turunen, T Muhonen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Decreasing CD4/CD8 ratio during prolonged four-drug chemotherapy plus interferon treatment for metastatic melanomaT Muhonen, M Hahka-Kemppinen, S Pakkala, et al.
Melanoma Research|June 1, 1996
Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?M Hahka-Kemppinen, T Muhonen, L Kangas, et al.
Melanoma Research|August 1, 1997
DNA flow cytometry and the outcome of chemoimmunotherapy in metastatic melanomaM Hahka-Kemppinen, T Muhonen, S Nordling, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1996
Radiation therapy of intracranial malignant melanomaO P Isokangas, T Muhonen, M Kajanti, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagusM Kajanti, R Kaleta, L Kankaanranta, et al.
Pageof 6